ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
0.00%
US Tech 100
17,318.40
0.45%
다우존스 지수
38,239.66
0.00%
Bitcoin
62,232.00
-1.21%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Neoleukin Therapeutics Inc (NLTX)

  7. Neoleukin Therapeutics Inc (NLTX) 뉴스

NLTX Neoleukin Therapeutics Inc

3.49
0.00 (0.00%)
시간외 단일가
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Neoleukin Therapeutics Inc NLTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 3.49 09:00:00
개장가 저가 고가 종가 전일 종가
3.49
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
27/04/202403:34EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/04/202403:33EDGAR2Form ARS - Annual Report to Security Holders
27/04/202403:33EDGAR2Form DEF 14A - Other definitive proxy statements
23/04/202405:44EDGAR2Form 8-K - Current report
03/04/202404:43EDGAR2Form 8-K - Current report
19/03/202405:10EDGAR2Form 8-K - Current report
19/03/202405:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/03/202409:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/03/202409:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/03/202409:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:29EDGAR2Form 144 - Report of proposed sale of securities
05/03/202408:20EDGAR2Form 144 - Report of proposed sale of securities
04/03/202421:30EDGAR2Form 8-K - Current report
22/02/202406:07EDGAR2Form 8-K - Current report
21/02/202406:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/02/202408:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/02/202406:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/02/202405:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202423:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/02/202406:18EDGAR2Form 144 - Report of proposed sale of securities
19/01/202409:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/01/202421:11EDGAR2Form 8-K - Current report
27/12/202308:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/12/202308:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/12/202308:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/12/202308:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/12/202308:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/12/202306:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/12/202306:05EDGAR2Form SC 13D - General statement of acquisition of beneficial..
19/12/202321:31EDGAR2Form 8-K - Current report
15/12/202309:00GLOBENeoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
07/12/202306:24EDGAR2Form 425 - Prospectuses and communications, business..
07/12/202306:21EDGAR2Form 8-K - Current report
05/12/202307:14EDGAR2Form 425 - Prospectuses and communications, business..
05/12/202307:10EDGAR2Form 8-K - Current report
01/12/202306:06EDGAR2Form 425 - Prospectuses and communications, business..
09/11/202304:34EDGAR2Form S-4/A - Registration of securities, business..
19/10/202305:09EDGAR2Form S-4/A - Registration of securities, business..
06/10/202301:50EDGAR2Form 425 - Prospectuses and communications, business..
29/09/202305:28EDGAR2Form S-4/A - Registration of securities, business..
22/09/202321:03EDGAR2Form 8-K - Current report
22/09/202321:00GLOBENeoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
15/08/202305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202305:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

최근 히스토리

NASDAQ
NLTX
Neoleukin Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유